Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer: Analysis of the MOSAIC and PETACC-8 Trials.

Fiche publication


Date publication

juillet 2019

Journal

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr LEPAGE Côme, Dr VERNEREY Dewi


Tous les auteurs :
Auclin E, Taieb J, Lepage C, Aparicio T, Faroux R, Mini E, Folprecht G, Salazar R, Benetkiewicz M, Banzi M, Louvet C, Van Laethem JL, Tabernero J, Hickish T, de Gramont A, André T, Vernerey D

Résumé

We explored and validated the association of postoperative carcinoembryonic antigen (CEA) with disease-free survival (DFS) and overall survival (OS) in stage III colon cancer.

Référence

Cancer Epidemiol. Biomarkers Prev.. 2019 Jul;28(7):1153-1161